Krystal Biotech, Inc.

Krystal Biotech is a commercial-stage biotechnology company focused on the discovery, development, and commercialization of genetic medicines. The company utilizes a proprietary redosable HSV vector platform to develop gene therapies targeting diseases with high unmet medical needs. Krystal's first commercial product, VYJUVEK®, is the first and only redosable gene therapy for the treatment of dystrophic epidermolysis bullosa, a rare and severe genetic blistering disease. The company is rapidly advancing its pipeline of investigational genetic medicines across various therapeutic areas, including respiratory, oncology, dermatology, ophthalmology, and aesthetics.

Krystal Biotech is headquartered in Pittsburgh, Pennsylvania, and is led by an experienced management team. The company is fully integrated and has core capabilities in viral vector design, vector optimization, gene therapy manufacturing, and commercialization. Krystal is committed to providing transformative genetic medicines to patients while ensuring access and success through its patient-centric approach.

Krystal Biotech values its employees and offers a flexible work environment. This includes the opportunity to work remotely, allowing for a better work-life balance and the ability to manage personal commitments more effectively. While specific details about the extent of flexibility in different roles aren't provided, the company prioritizes employee well-being and promotes a culture that allows for flexibility and adaptability.

Krystal Biotech is a commercial-stage biotechnology company dedicated to developing and delivering redosable gene therapies for patients with severe, life-threatening, or rare diseases. They focus on providing treatment options for those with limited or no approved therapies, working to improve the lives of individuals affected by genetic diseases. Their mission is to make these innovative genetic medicines accessible and successful, changing the way genetic diseases are treated using a first-in-class approach.

Krystal Biotech promotes a culture centered around a shared purpose: to discover, develop, and commercialize genetic medicines to improve the lives of patients with high unmet medical needs. This mission drives the company's focus on innovation, collaboration, and a patient-first approach. They emphasize transparency and integrity in their relationships with patients, advocacy groups, and the healthcare community. The company fosters a sense of purpose and dedication among its employees, creating a workplace that values teamwork, scientific excellence, and the impact they make on the lives of patients.

Krystal Biotech is committed to building a diverse, equitable, and inclusive workplace. The company values the unique perspectives and experiences of all employees and believes that fostering a culture of inclusion is essential for innovation and success. Krystal actively works to attract, develop, and retain a diverse workforce by implementing initiatives to promote equity in hiring, training, and promotion. They also prioritize creating a welcoming and supportive environment where all employees feel valued and respected, regardless of their background or identity.